Overview: Stone Analysis with Picture TestIntroduction: The Stone Analysis with Picture Test analyzes kidney stone composition to diagnose stone type, causing pain or blood in urine. Following 2023 AUA guidelines, it uses biochemical methods for high specificity, supporting renal screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in clinical pathology for patients with suspected kidney stones.
Other Names: Kidney Stone Analysis, Urolithiasis Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Stone analysis began in the 1800s with urinalysis research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Analyzes kidney stone composition to diagnose stone type, guides treatment, and evaluates patients with pain or blood in urine.
Test Parameters: 1. Stone Composition
Pretest Condition: No fasting required. Collect kidney stones. Report history of pain, blood in urine, or kidney stone episodes.
Specimen: Kidney Stone (sterile container, 1-5 stones). Transport in a biohazard container.
Sample Stability at Room Temperature: Indefinite
Sample Stability at Refrigeration: Indefinite
Sample Stability at Frozen: Indefinite
Medical History: Document pain, hematuria, or history of kidney stones. Include current medications, especially diuretics.
Consent: Written consent required, detailing the tests purpose, kidney stone implications, and risks of sample collection.
Procedural Considerations: Uses infrared spectroscopy or X-ray diffraction to analyze stone composition, with photographic documentation. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for kidney stone diagnosis.
Factors Affecting Result Accuracy: Incomplete stone collection or contamination can affect results. Stone size impacts analysis.
Clinical Significance: Identified stone composition (e.g., calcium oxalate, uric acid) guides dietary or medical therapy. Recurrence risk assessment is enhanced.
Specialist Consultation: Consult a urologist or nephrologist for result interpretation and treatment planning.
Additional Supporting Tests: Urine calcium, uric acid, or renal imaging to confirm kidney stone diagnosis.
Test Limitations: Limited to collected stones; clinical correlation is needed. Sample quality affects accuracy.
References: AUA Urolithiasis Guidelines, 2023; Journal of Urology, Pearle MS, 2022.
